Skip to main content

. 1990 Dec;62(6):1031–1033. doi: 10.1038/bjc.1990.433

Comparative values of several tumour markers: example of untreated breast carcinoma.

J L Cazin ¹, P Gosselin ¹, B Boniface ¹, M C Demaille ¹, M Boniface ¹, A Demaille ¹

PMCID: PMC1971564 PMID: 2257208

1031

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Gosselin P., Cazin J. L., Demaille M. C., Sulman C. Place des marqueurs tumoraux dans les néoplasies mammaires et gynécologiques. Rev Fr Gynecol Obstet. 1988 Jul-Sep;83(7-9):535–540. [PubMed] [Google Scholar]
Hanley J. A., McNeil B. J. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983 Sep;148(3):839–843. doi: 10.1148/radiology.148.3.6878708. [DOI] [PubMed] [Google Scholar]
Hanley J. A., McNeil B. J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982 Apr;143(1):29–36. doi: 10.1148/radiology.143.1.7063747. [DOI] [PubMed] [Google Scholar]
Jotti G. S., Bombardieri E. Circulating tumor markers in breast cancer (review). Anticancer Res. 1990 Jan-Feb;10(1):253–258. [PubMed] [Google Scholar]
Makuch R. W., Muenz L. R. Evaluating the adequacy of tumor markers to discriminate among distinct populations. Semin Oncol. 1987 Jun;14(2):89–101. [PubMed] [Google Scholar]
McNeil B. J., Hanley J. A. Statistical approaches to the analysis of receiver operating characteristic (ROC) curves. Med Decis Making. 1984;4(2):137–150. doi: 10.1177/0272989X8400400203. [DOI] [PubMed] [Google Scholar]
Metz C. E. Basic principles of ROC analysis. Semin Nucl Med. 1978 Oct;8(4):283–298. doi: 10.1016/s0001-2998(78)80014-2. [DOI] [PubMed] [Google Scholar]
Pons-Anicet D. M., Krebs B. P., Mira R., Namer M. Value of CA 15:3 in the follow-up of breast cancer patients. Br J Cancer. 1987 May;55(5):567–569. doi: 10.1038/bjc.1987.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
Schmidt-Rhode P., Schulz K. D., Sturm G., Raab-Frick A., Prinz H. CA 15.3 as a tumour marker in breast cancer. Int J Biol Markers. 1987 Sep-Dec;2(3):135–142. doi: 10.1177/172460088700200301. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES